Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18407822 | 0.74 | CYP2A13 (0.33) | ALDH1A1CYP2A13HPGD | |
| SCHEMBL6999817 | 0.68 | ALDH1A1 (0.38) | SMN1; SMN2GAAALDH1A1CYP2A13HPGD | |
| SCHEMBL19773458 | 0.61 | CYP2A13 (0.38) | SMN1; SMN2GAAALDH1A1CYP2A13HPGD | |
| SCHEMBL1760699 | 0.58 | SMN1; SMN2 (0.41) | SMN1; SMN2GAAALDH1A1CYP2A13 | |
| SCHEMBL16840093 | 0.58 | CYP2A13 (0.59) | SMN1; SMN2ALDH1A1CYP2A13HPGD | |
| SCHEMBL3634645 | 0.57 | CYP2A13 (0.41) | SMN1; SMN2LMNAALDH1A1CYP2A13HPGD | |
| SCHEMBL3634647 | 0.57 | CYP2A13 (0.41) | SMN1; SMN2LMNAALDH1A1CYP2A13HPGD | |
| SCHEMBL21827557 | 0.57 | CYP2A13 (0.41) | SMN1; SMN2LMNAALDH1A1CYP2A13HPGD | |
| SCHEMBL15854999 | 0.56 | ALDH1A1 (0.44) | SMN1; SMN2ALDH1A1CYP2A13HPGD | |
| SCHEMBL1699950 | 0.56 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNAALDH1A1CYP2A13HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9669032-B2 | Enhanced treatment regimens using mTOR inhibitors | INTELLIKINE LLC (US) | 2017-06-06 | — | — | US | disclosed |